A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)
Clinical trial NCT06908226 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06908226
- Sponsor
- Longboard Pharmaceuticals
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-12
- Primary completion
- 2027-11-11
- Enrollment
- 324
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.